« Previous AbstractDiscrimination of SARS-CoV-2 Infections From Other Viral Respiratory Infections by Scent Detection Dogs    Next AbstractElectronic nose in discrimination of children with uncontrolled asthma »

Front Pediatr

Title:		Measuring Airway Inflammation in Asthmatic Children
Author(s):		Tenero L; Zaffanello M; Piazza M; Piacentini G;
Address:		"Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy"
Journal Title:		Front Pediatr
Year:		2018
Volume:		20180706
Issue:
Page Number:		196 -
DOI:		10.3389/fped.2018.00196
ISSN/ISBN:		2296-2360 (Print) 2296-2360 (Electronic) 2296-2360 (Linking)
Abstract:		"Asthma is the most common chronic respiratory disease in children characterized by airways inflammation, bronchial hyperresponsiveness, recurrent reversible airways obstruction, and respiratory symptoms. The diagnosis of the disease is based on clinical history, airways obstruction at spirometry, and bronchial reversibility. Asthma treatment is aimed to disease control, through the use of controller treatment and monitoring lung function. However, lung function and symptoms not always reflect the underlying airways inflammation and response to the therapy. Objective parameters of asthma inflammation could be important for the clinician in the management of patients with asthma. In the last years, some studies were focused on biomarkers to identify phenotype, inflammation, and pathobiological pathways to help the clinician in the diagnosis and in personalizing the management. Accordingly, clinically feasible tests are represented by the collection of exhaled breath condensate (EBC) and measurement of exhaled nitric oxide (FeNO). Other-methods such as the evaluation of volatile organic compound (VOCs), that reflect airways inflammation and treatment efficacy, are currently used for research purposes For some of these methods, The lack of standardization in pre-collection, collection, post-collection of samples, and interpretation of the results may a problem in clinical practice. Improved these limitations, several biomarkers will be useful to distinguish patients with a different disease condition to personalize the treatment"
Keywords:		FeNO biomarkers exhaled breath condensate exhaled breath volatile compounds inflammation;
Notes:		"PubMed-not-MEDLINETenero, Laura Zaffanello, Marco Piazza, Michele Piacentini, Giorgio eng Review Switzerland 2018/07/24 Front Pediatr. 2018 Jul 6; 6:196. doi: 10.3389/fped.2018.00196. eCollection 2018"